DIETARY SUPPLEMENT HEALTH CLAIMS ADVISORY COMMITTEE TO FDA
This article was originally published in The Tan Sheet
DIETARY SUPPLEMENT HEALTH CLAIMS ADVISORY COMMITTEE TO FDA might help to overcome industry's perception of bias in the agency against dietary supplement health claims, FDA Special Assistant for Policy Mitch Zeller suggested at the U.S. Pharmacopeia open conference on nutritional supplements in Cambridge, Mass. on May 23. "If Congress were to mandate...an advisory committee to assist in the evaluation of health claims," Zeller said, "it would begin to overcome this perception of bias that some people have."
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC